UK markets open in 35 minutes

MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
3.970+0.020 (+0.51%)
As of 01:12PM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 1.66B
Enterprise value -406.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.17
Price/book (mrq)0.74
Enterprise value/revenue 5.13
Enterprise value/EBITDA -29.70

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-35.88%
S&P500 52-week change 323.49%
52-week high 36.800
52-week low 33.400
50-day moving average 34.040
200-day moving average 34.415

Share statistics

Avg vol (3-month) 3107.06k
Avg vol (10-day) 3141.51k
Shares outstanding 5169.18M
Implied shares outstanding 6404.01M
Float 891.36M
% held by insiders 135.77%
% held by institutions 125.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -49.37%
Operating margin (ttm)-97.57%

Management effectiveness

Return on assets (ttm)-5.77%
Return on equity (ttm)-5.85%

Income statement

Revenue (ttm)253.23M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)39.90%
Gross profit (ttm)N/A
EBITDA -195.02M
Net income avi to common (ttm)-125.02M
Diluted EPS (ttm)-0.320
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.89B
Total cash per share (mrq)4.44
Total debt (mrq)643.43k
Total debt/equity (mrq)0.03%
Current ratio (mrq)21.67
Book value per share (mrq)4.84

Cash flow statement

Operating cash flow (ttm)-153M
Levered free cash flow (ttm)-132.55M